Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-01-18-Speech-3-370-000"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20120118.26.3-370-000"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spoken text |
"Madam President, new legislation to replace the Biocidal Products Directive is absolutely necessary. I therefore want to congratulate Christa Klaß and all my other colleagues who worked on this dossier, on being able to find common ground with the Council and to reach a compromise agreement.
I am particularly pleased with the provisions for clear labelling, labelling of nanomaterials and the recognition that excessive restrictions on certain products may result in a disproportionately negative impact on society.
However, I would urge the Commission and Member States to be wary of the cost of compliance with the new legislation. We must make sure that the process of getting approval to use necessary products is not so great that the companies who need them cannot afford them. Intimidating costs may mean that many SMEs in my constituency in Scotland, and those in other countries, feel excluded from the entire process.
We must ensure a level playing field and prevent dominant companies from excluding smaller competitors. Just as excessive restrictions on certain products may result in a disproportionate negative impact on society, excessive costs of compliance will have a disproportionate impact on businesses, and particularly on SMEs, which make up a significant part of this sector."@en1
|
| lpv:spokenAs | |
| lpv:unclassifiedMetadata | |
| lpv:videoURI |
Named graphs describing this resource:
The resource appears as object in 2 triples